Insight Molecular (IMDX) Fundamental Analysis: Revenue, Earnings & Valuation

2.97 / 10

Underperform

Fundamental rating is Underperform with a 3/10 score. Revenue‑MV and Cash‑MV are modestly positive, yet Fixed‑assets turnover and Income‑tax/Profit ratios are weak. Overall, the fundamentals are considered inadequate, suggesting a cautious view.

Analysis Checks(6/10)

Revenue-MV

Value-4.31

Score2/3

Weight34.03%

1M Return8.45%

Total operating revenue (YoY growth rate %)

Value115.58

Score1/3

Weight-9.90%

1M Return-3.06%

Inventory turnover ratio

Value4.29

Score2/3

Weight-3.90%

1M Return-1.21%

Gross profit margin (%)

Value56.67

Score2/3

Weight6.33%

1M Return1.69%

PB-ROE

Value1.10

Score0/3

Weight13.96%

1M Return3.23%

Income tax / Total profit (%)

Value0.00

Score1/3

Weight-1.60%

1M Return-0.50%

Fixed assets turnover ratio

Value0.64

Score1/3

Weight-3.87%

1M Return-1.24%

Cost of sales ratio (%)

Value43.33

Score2/3

Weight-13.33%

1M Return-4.42%

Asset-MV

Value-0.49

Score2/3

Weight53.64%

1M Return12.22%

Cash-MV

Value-0.09

Score2/3

Weight24.64%

1M Return5.94%

Is IMDX undervalued or overvalued?

IMDX scores 2.97/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.00% ROE, -1238.52% net margin, -1.97 P/E ratio, -3.14 P/B ratio, and 64.59% earnings growth, these metrics solidify its Underperform investment rating.